Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-06-30 Nicholson Garry A Director Grant or award · Stock Option (Right to Buy) +67,000 67,000
2025-06-30 Woods Keith Director Grant or award · Stock Option (Right to Buy) +67,000 67,000
2025-06-30 Dorton Katina Director Grant or award · Stock Option (Right to Buy) +67,000 67,000
2025-06-30 Gruia Gabriela Director Grant or award · Stock Option (Right to Buy) +67,000 67,000
2025-05-20 Lynx1 Capital Management LP 10% owner Purchase +1,200,000 $1.20 $1.4M 7,946,141
2025-05-19 Lynx1 Capital Management LP 10% owner Purchase +1,388,794 $1.20 $1.7M 6,746,141
2025-01-03 ZDRAVESKI ZORAN See Remarks Grant or award · Stock Option (Right to Buy) +250,000 250,000
2025-01-03 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +800,000 800,000
2025-01-03 Amello Jason Chief Financial Officer Grant or award · Stock Option (Right to Buy) +270,000 270,000
2025-01-03 Louis Chrystal Chief Medical Officer Grant or award · Stock Option (Right to Buy) +400,000 400,000
2024-12-26 Lynx1 Capital Management LP 10% owner Purchase · Pre-funded Warrant (right to buy) +7,500,000 $4.00 $30.0M 7,500,000
2024-12-13 Lynx1 Capital Management LP 10% owner Purchase +100,000 $2.90 $290K 5,357,347
2024-12-12 Lynx1 Capital Management LP 10% owner Purchase +31,800 $3.01 $96K 5,257,347
2024-11-15 Lynx1 Capital Management LP 10% owner Purchase +947 $4.34 $4K 5,225,547
2024-09-23 Klencke Barbara Director Purchase +5,000 $5.29 $26K 45,000
2024-08-26 Klencke Barbara Director Purchase +5,000 $5.53 $28K 40,000
2024-08-23 Klencke Barbara Director Purchase +5,000 $5.69 $28K 35,000
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise +54,895 $4.85 $266K 67,111
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise +25,000 $3.27 $82K 92,111
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise +13,125 $1.81 $24K 105,236

Page 2 of 8 · 144 trades